CLINICAL_TRIALS
trial_result
· 2022-11-09
Clinical Trial Update: Fenfluramine for Adult Dravet Patients [Phase 3]
Summary
Trial update for fenfluramine in adult Dravet patients is in Phase 3 with unclear status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Health Network, Toronto | Conditions: Dravet Syndrome, Dravet Syndrome, Intractable | Phase 3 | Status: UNKNOWN